Neuroscience of addiction: relevance to prevention and treatment
ND Volkow, M Boyle - American Journal of Psychiatry, 2018 - Am Psychiatric Assoc
Addiction, the most severe form of substance use disorder, is a chronic brain disorder
molded by strong biosocial factors that has devastating consequences to individuals and to …
molded by strong biosocial factors that has devastating consequences to individuals and to …
Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions
M Gaba, C Mohan - Medicinal Chemistry Research, 2016 - Springer
Imidazole and benzimidazole rings are the most important nitrogen-containing heterocycles,
which are widely explored and utilized by the pharmaceutical industry for drug discovery …
which are widely explored and utilized by the pharmaceutical industry for drug discovery …
Alpha2‐adrenergic agonists for the management of opioid withdrawal
Background Withdrawal is a necessary step prior to drug‐free treatment or as the endpoint
of long‐term substitution treatment. Objectives To assess the effectiveness of interventions …
of long‐term substitution treatment. Objectives To assess the effectiveness of interventions …
Hallucinogen persisting perception disorder: etiology, clinical features, and therapeutic perspectives
Hallucinogen Persisting Perception Disorder (HPPD) is a rare, and therefore, poorly
understood condition linked to hallucinogenic drugs consumption. The prevalence of this …
understood condition linked to hallucinogenic drugs consumption. The prevalence of this …
Anticraving medications for relapse prevention: a possible new class of psychoactive medications
CP O'Brien - American Journal of Psychiatry, 2005 - Am Psychiatric Assoc
Psychiatrists have gradually developed a list of medications that are effective in the
treatment of addictive disorders. Although alcoholism has received the most attention …
treatment of addictive disorders. Although alcoholism has received the most attention …
Opioid dependence treatment: options in pharmacotherapy
AL Stotts, CL Dodrill, TR Kosten - Expert opinion on …, 2009 - Taylor & Francis
The development of effective treatments for opioid dependence is of great importance given
the devastating consequences of the disease. Pharmacotherapies for opioid addiction …
the devastating consequences of the disease. Pharmacotherapies for opioid addiction …
Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal
JL Scavone, RC Sterling, EJ Van Bockstaele - Neuroscience, 2013 - Elsevier
Withdrawal from opiates, such as heroin or oral narcotics, is characterized by a host of
aversive physical and emotional symptoms. High rates of relapse and limited treatment …
aversive physical and emotional symptoms. High rates of relapse and limited treatment …
Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment.
SM Hyman, H Fox, KIA Hong, C Doebrick… - Experimental and …, 2007 - psycnet.apa.org
Background: Naltrexone is a nonaddictive medication that blocks the euphoric effects of
opioids. However, naltrexone treatment is associated with high rates of noncompliance and …
opioids. However, naltrexone treatment is associated with high rates of noncompliance and …
Opioid antagonists with minimal sedation for opioid withdrawal
Background Managed withdrawal is a necessary step prior to drug‐free treatment or as the
endpoint of long‐term substitution treatment. Objectives To assess the effects of opioid …
endpoint of long‐term substitution treatment. Objectives To assess the effects of opioid …
Evidence-based treatments of addiction
CP O'Brien - … Transactions of the Royal Society B …, 2008 - royalsocietypublishing.org
Both pharmacotherapy and behavioural treatment are required to relieve the symptoms of
addictive disorders. This paper reviews the evidence for the benefits of pharmacotherapy …
addictive disorders. This paper reviews the evidence for the benefits of pharmacotherapy …